1. Home
  2. KHC vs RVMD Comparison

KHC vs RVMD Comparison

Compare KHC & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Kraft Heinz Company

KHC

The Kraft Heinz Company

HOLD

Current Price

$24.91

Market Cap

27.8B

ML Signal

HOLD

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$204.80

Market Cap

30.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KHC
RVMD
Founded
1869
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.8B
30.1B
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
KHC
RVMD
Price
$24.91
$204.80
Analyst Decision
Hold
Strong Buy
Analyst Count
17
19
Target Price
$24.50
$140.84
AVG Volume (30 Days)
19.0M
1.7M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
7.14%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$24,942,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.58
$533.02
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.04
$42.18
52 Week High
$28.09
$224.31

Technical Indicators

Market Signals
Indicator
KHC
RVMD
Relative Strength Index (RSI) 47.03 45.37
Support Level $24.14 $198.91
Resistance Level $25.47 $222.33
Average True Range (ATR) 0.62 7.99
MACD -0.10 -2.08
Stochastic Oscillator 32.97 12.52

Price Performance

Historical Comparison
KHC
RVMD

About KHC The Kraft Heinz Company

In July 2015, Kraft merged with Heinz to create one of North America's largest food and beverage manufacturers. Beyond its namesake brands, its portfolio includes Oscar Mayer, Velveeta, and Philadelphia. While the retail channel drives around 85% of its total sales, the firm also maintains a growing foodservice presence. Outside North America, Kraft Heinz's global reach encompasses a distribution network in Europe and emerging markets, which accounts for around 25% of its consolidated sales base. The company's products are sold in more than 190 countries and territories.

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

Share on Social Networks: